Carella M J, Srivastava L S, Gossain V V, Rovner D R
Department of Medicine, Michigan State University, East Lansing 48824.
J Clin Endocrinol Metab. 1993 May;76(5):1188-91. doi: 10.1210/jcem.76.5.8388401.
"Steroid burst therapy" is commonly used for various acute medical conditions, but its suppressive effect on hypothalamic-pituitary-adrenocortical (HPA) function and the time period for recovery of HPA function is not fully known. We therefore evaluated the HPA function in 10 normal adults before and after a short burst of Prednisone (40 mg/three times daily for 3 days, then tapered over the next 4 days). HPA function was evaluated by iv administration of 100 micrograms of ovine CRH (oCRH) and blood samples for ACTH and cortisol assay were obtained at -30,0,10,15,30,60,90, and 120 min. On another day, 250 micrograms synthetic ACTH (Cosyntropin) were given iv and blood samples for cortisol were obtained at 0,30,60, and 90 min. Basal and peak levels of ACTH and cortisol before and 1,2, and 3 weeks after discontinuation of prednisone in response to oCRH iv are shown below (see Table 1). All values are mean (SEM). Peak levels of cortisol after iv administration of Cosyntropin at week 0 were 922(56.8), week 1 899(63.7), week 2 861(70.9), and week 3 855(53.0). There was no significant difference noted in the levels of ACTH and cortisol in response to oCRH before and after prednisone treatment. Pre- and posttreatment responses of cortisol to Cosyntropin administration were also similar. In addition, cumulative responses (area under the curve) and the change from baseline (delta) before and after administration of prednisone were similar for ACTH and cortisol. We conclude that HPA function is normal 1 week after discontinuation of a short burst of prednisone. These findings suggest that administration of additional steroids may not be required during periods of "stress" for those patients who have previously received similar steroid burst therapy, if at least 1 week has elapsed after such treatment was given.
“类固醇冲击疗法”常用于各种急性病症,但其对下丘脑 - 垂体 - 肾上腺皮质(HPA)功能的抑制作用以及HPA功能恢复的时间段尚不完全清楚。因此,我们评估了10名正常成年人在短期服用泼尼松(40毫克/每日三次,共3天,然后在接下来4天逐渐减量)前后的HPA功能。通过静脉注射100微克羊促肾上腺皮质激素释放激素(oCRH)评估HPA功能,并在 -30、0、10、15、30、60、90和120分钟采集血样用于促肾上腺皮质激素(ACTH)和皮质醇检测。在另一天,静脉注射250微克合成促肾上腺皮质激素(考的松),并在0、30、60和90分钟采集血样用于皮质醇检测。泼尼松停药后1、2和3周,静脉注射oCRH前后ACTH和皮质醇的基础水平及峰值水平如下所示(见表1)。所有数值均为平均值(标准误)。第0周静脉注射考的松后皮质醇的峰值水平为922(56.8),第1周为899(63.7),第2周为861(70.9),第3周为855(53.0)。泼尼松治疗前后,oCRH刺激下ACTH和皮质醇水平无显著差异。皮质醇对考的松给药的治疗前和治疗后反应也相似。此外,泼尼松给药前后ACTH和皮质醇的累积反应(曲线下面积)以及相对于基线的变化(差值)相似。我们得出结论,短期泼尼松冲击治疗停药1周后HPA功能正常。这些发现表明,对于之前接受过类似类固醇冲击治疗的患者,如果在治疗后至少已过去1周,那么在“应激”期间可能无需额外给予类固醇。